Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
-43.1%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.16% |
| Q3 2025 | 7.99% |
| Q2 2025 | -1.15% |
| Q1 2025 | 32.83% |
| Q4 2024 | 0.18% |
| Q3 2024 | -0.14% |
| Q2 2024 | 7.89% |
| Q1 2024 | 31.56% |
| Q4 2023 | -1.06% |
| Q3 2023 | 42.03% |
| Q2 2023 | -10.55% |
| Q1 2023 | -7.31% |
| Q4 2022 | -3.64% |
| Q3 2022 | -6.47% |
| Q2 2022 | 39.31% |
| Q1 2022 | 1.44% |
| Q4 2021 | -6.04% |
| Q3 2021 | -6.41% |
| Q2 2021 | 4.90% |
| Q1 2021 | 12.78% |
| Q4 2020 | 86.55% |
| Q3 2020 | 63.92% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |